|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gastrointestinal Imaging |
1 From the Departments of Radiology (C.D., T.d.B., V.K., P.P., A.R., R.B.), Surgery (D.E.), and Medicine (M.D., V.B.), Institut Gustave-Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France. From the 1999 RSNA scientific assembly. Received April 16, 2001; revision requested June 4; revision received July 30; accepted September 17. Address correspondence to C.D. (e-mail: dromain@igr.fr).
PURPOSE: To describe the appearance of hepatic tumors treated with radio-frequency (RF) ablation on computed tomographic (CT) and magnetic resonance (MR) images and the pattern of residual tumor at the site of RF ablation and to assess prospectively the sensitivity, specificity, and positive and negative predictive CT and MR imaging values in the evaluation of RF treatment.
MATERIALS AND METHODS: Thirty-one patients with 50 tumors (nine hepatocellular carcinomas and 41 metastases) treated with RF ablation underwent CT and MR imaging on the same day at 2, 4, and 6 months; CT was performed every 3 months thereafter. CT and MR findings were interpreted separately and prospectively by two reviewers with consensus. For both imaging techniques, appearance of the treated area, treatment efficacy, and complications were assessed at each time. Sensitivity and specificity were determined by using the McNemar test.
RESULTS: After a mean follow-up of 19 months, nine tumors showed local regrowth. At 2 months, MR imaging depicted more local regrowths (eight of nine; sensitivity, 89%) than did CT (four of nine; sensitivity, 44%) but without significant differences (P = .12). In two cases, only T2-weighted imaging depicted local regrowth. All nine lesions became conspicuous at 4-month follow-up with both techniques. At 2 months, thin peripheral rim enhancement and arterioportal shunting were found in 24% and 12%, respectively, of the treated tumors. These findings disappeared thereafter and are not linked to tumor regrowth.
CONCLUSION: Despite the small number of patients, CT and MR imaging may depicted all local regrowth at 4 months or sooner. MR imaging may have an edge over CT in the early detection of local regrowth.
© RSNA, 2002
Index terms: Liver neoplasms, CT, 76.12111, 76.12112, 76.113, 76.12115 Liver neoplasms, MR, 76.121411, 76.121412, 76.121415, 76.12143 Liver neoplasms, therapy, 76.1269, 76.323 Radiofrequency (RF) ablation, 76.1269
This article has been cited by other articles:
![]() |
T. de Baere, F. Deschamps, P. Briggs, C. Dromain, V. Boige, L. Hechelhammer, M. Abdel-Rehim, A. Auperin, D. Goere, and D. Elias Hepatic Malignancies: Percutaneous Radiofrequency Ablation during Percutaneous Portal or Hepatic Vein Occlusion Radiology, September 1, 2008; 248(3): 1056 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mulier, T. Ruers, L. Michel, J. Jamart, G. Marchal, and Y. Ni A Place for Radiofrequency Ablation in the Treatment of Resectable Colorectal Liver Metastases? Ann. Surg. Oncol., July 1, 2008; 15(7): 2064 - 2065. [Full Text] [PDF] |
||||
![]() |
J. M. Willatt, H. K. Hussain, S. Adusumilli, and J. A. Marrero MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies Radiology, May 1, 2008; 247(2): 311 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-h. Park, H. Rhim, Y.-s. Kim, D. Choi, H. K. Lim, and W. J. Lee Spectrum of CT Findings after Radiofrequency Ablation of Hepatic Tumors RadioGraphics, March 1, 2008; 28(2): 379 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Arellano Invited Commentary RadioGraphics, March 1, 2008; 28(2): 390 - 392. [Full Text] [PDF] |
||||
![]() |
A. P. S. Kirkham, M. Emberton, I. M. Hoh, R. O. Illing, A. A. Freeman, and C. Allen MR Imaging of Prostate after Treatment with High-Intensity Focused Ultrasound Radiology, March 1, 2008; 246(3): 833 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Vogt, G. Antoch, P. Veit, L. S. Freudenberg, N. Blechschmid, O. Diersch, A. Bockisch, J. Barkhausen, and H. Kuehl Morphologic and Functional Changes in Nontumorous Liver Tissue After Radiofrequency Ablation in an In Vivo Model: Comparison of 18F-FDG PET/CT, MRI, Ultrasound, and CT J. Nucl. Med., November 1, 2007; 48(11): 1836 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. V. Vogel, J. A. van Dalen, B. Wiering, H. Huisman, F. H.M. Corstens, T. J.M. Ruers, and W. J.G. Oyen Evaluation of Image Registration in PET/CT of the Liver and Recommendations for Optimized Imaging J. Nucl. Med., June 1, 2007; 48(6): 910 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Keppke, R. Salem, D. Reddy, J. Huang, J. Jin, A. C. Larson, and F. H. Miller Imaging of Hepatocellular Carcinoma After Treatment with Yttrium-90 Microspheres Am. J. Roentgenol., March 1, 2007; 188(3): 768 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bricault, R. Kikinis, P. R. Morrison, E. vanSonnenberg, K. Tuncali, and S. G. Silverman Liver Metastases: 3D Shape-based Analysis of CT Scans for Detection of Local Recurrence after Radiofrequency Ablation Radiology, October 1, 2006; 241(1): 243 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. d. Baere, J. Palussiere, A. Auperin, A. Hakime, M. Abdel-Rehim, M. Kind, C. Dromain, A. Ravaud, N. Tebboune, V. Boige, et al. Midterm Local Efficacy and Survival after Radiofrequency Ablation of Lung Tumors with Minimum Follow-up of 1 Year: Prospective Evaluation. Radiology, August 1, 2006; 240(2): 587 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-Y. Brillet, V. Paradis, G. Brancatelli, A.-S. Rangheard, Y. Consigny, A. Plessier, F. Durand, J. Belghiti, D. Sommacale, and V. Vilgrain Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison. Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S296 - S305. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Frericks, J. P. Ritz, A. Roggan, K.-J. Wolf, and T. Albrecht Multipolar Radiofrequency Ablation of Hepatic Tumors: Initial Experience Radiology, December 1, 2005; 237(3): 1056 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shankar, E. vanSonnenberg, J. Desai, P. J. DiPiro, A. Van Den Abbeele, and G. D. Demetri Gastrointestinal Stromal Tumor: New Nodule-within-a-Mass Pattern of Recurrence after Partial Response to Imatinib Mesylate Radiology, June 1, 2005; 235(3): 892 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Pandharipande, G. A. Krinsky, H. Rusinek, and V. S. Lee Perfusion Imaging of the Liver: Current Challenges and Future Goals Radiology, March 1, 2005; 234(3): 661 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. K. Lu, N. C. Yu, S. S. Raman, P. Limanond, C. Lassman, K. Murray, M. J. Tong, R. G. Amado, and R. W. Busuttil Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Success as Defined by Histologic Examination of the Explanted Liver Radiology, March 1, 2005; 234(3): 954 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kim, W. K. Moon, J. H. Cha, J. M. Goo, K. H. Lee, K. H. Kim, J. W. Lee, J. G. Han, H.-J. Weinmann, and K. H. Chang VX2 Carcinoma in Rabbits after Radiofrequency Ablation: Comparison of MR Contrast Agents for Help in Differentiating Benign Periablational Enhancement from Residual Tumor Radiology, February 1, 2005; 234(2): 423 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, H. K. Lim, D. Choi, W. J. Lee, S. H. Kim, M. J. Kim, S. J. Lee, and J. H. Lim Changes in Bile Ducts after Radiofrequency Ablation of Hepatocellular Carcinoma: Frequency and Clinical Significance Am. J. Roentgenol., December 1, 2004; 183(6): 1611 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Y. Jin, J. M. Lee, Y. C. Lee, Y. M. Han, and Y. S. Lim Primary and Secondary Lung Malignancies Treated with Percutaneous Radiofrequency Ablation: Evaluation with Follow-Up Helical CT Am. J. Roentgenol., October 1, 2004; 183(4): 1013 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gadaleta, V. Mattioli, G. Colucci, A. Cramarossa, V. Lorusso, E. Canniello, A. Timurian, G. Ranieri, G. Fiorentini, M. De Lena, et al. Radiofrequency Ablation of 40 Lung Neoplasms: Preliminary Results Am. J. Roentgenol., August 1, 2004; 183(2): 361 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Limanond, P. Zimmerman, S. S. Raman, B. M. Kadell, and D. S. K. Lu Interpretation of CT and MRI After Radiofrequency Ablation of Hepatic Malignancies Am. J. Roentgenol., December 1, 2003; 181(6): 1635 - 1640. [Full Text] [PDF] |
||||
![]() |
T. de Baere, O. Risse, V. Kuoch, C. Dromain, C. Sengel, T. Smayra, M. G. E. Din, C. Letoublon, and D. Elias Adverse Events During Radiofrequency Treatment of 582 Hepatic Tumors Am. J. Roentgenol., September 1, 2003; 181(3): 695 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Titton, P. C. Gryzenia, D. A. Gervais, R. S. Arellano, G. W. Boland, and P. R. Mueller Continuous High-Output Drainage of Hepatic Abscess 3 Months After Radiofrequency Ablation of Hepatocellular Carcinoma Am. J. Roentgenol., April 1, 2003; 180(4): 1079 - 1084. [Full Text] [PDF] |
||||
![]() |
S. K. Kim, H. K. Lim, Y. H. Kim, W. J. Lee, S. J. Lee, S. H. Kim, J. H. Lim, and S. A. Kim Hepatocellular Carcinoma Treated with Radio-frequency Ablation: Spectrum of Imaging Findings RadioGraphics, January 1, 2003; 23(1): 107 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
A M Connors and S P Blake Multiple-choice questionnaire: general Imaging, October 1, 2002; 14(5): 428 - 437. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |